From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.creatorMa, Cuiqing-
Autor(es): dc.creatorSu, Shan-
Autor(es): dc.creatorWang, Jiachao-
Autor(es): dc.creatorWei, Lin-
Autor(es): dc.creatorDu, Lanying-
Autor(es): dc.creatorJiang, Shibo-
Data de aceite: dc.date.accessioned2026-02-09T11:16:36Z-
Data de disponibilização: dc.date.available2026-02-09T11:16:36Z-
Data de envio: dc.date.issued2020-05-26-
Data de envio: dc.date.issued2020-05-26-
Data de envio: dc.date.issued2020-05-
Fonte completa do material: dc.identifierhttps://repositorio.ufla.br/handle/1/41226-
Fonte completa do material: dc.identifierhttps://www.sciencedirect.com/science/article/pii/S1286457920300824-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/1137398-
Descrição: dc.descriptionThe global pandemic of COVID-19 caused by SARS-CoV-2 (also known as 2019-nCoV and HCoV-19) has posed serious threats to public health and economic stability worldwide, thus calling for development of vaccines against SARS-CoV-2 and other emerging and reemerging coronaviruses. Since SARS-CoV-2 and SARS-CoV have high similarity of their genomic sequences and share the same cellular receptor (ACE2), it is essential to learn the lessons and experiences from the development of SARS-CoV vaccines for the development of SARS-CoV-2 vaccines. In this review, we summarized the current knowledge on the advantages and disadvantages of the SARS-CoV vaccine candidates and prospected the strategies for the development of safe, effective and broad-spectrum coronavirus vaccines for prevention of infection by currently circulating SARS-CoV-2 and other emerging and reemerging coronaviruses that may cause future epidemics or pandemics.-
Idioma: dc.languageen-
Publicador: dc.publisherElsevier-
Direitos: dc.rightsrestrictAccess-
???dc.source???: dc.sourceMicrobes and Infection-
Palavras-chave: dc.subject2019-nCoV-
Palavras-chave: dc.subjectSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-
Palavras-chave: dc.subjectSevere Acute Respiratory Syndrome Coronavirus (SARS-CoV)-
Palavras-chave: dc.subjectVaccine-
Palavras-chave: dc.subjectCross-protection-
Título: dc.titleFrom SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development-
Tipo de arquivo: dc.typeArtigo-
Aparece nas coleções:Repositório Institucional da Universidade Federal de Lavras (RIUFLA)

Não existem arquivos associados a este item.